Sunday, July 3, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Infectious Emerging Diseases

Researchers unlock TB vaccine puzzle in findings that could save millions of newborns

May 6, 2020
in Infectious Emerging Diseases
0
Share on FacebookShare on Twitter

An international research team has identified the mechanism behind one of science’s most enduring mysteries: what makes the 100-year-old tuberculosis (TB) vaccine so effective at preventing newborn deaths from diseases other than TB?

The ability of Bacillus Calmette-Guérin (BCG)–one of the oldest, safest and cheapest vaccines available–to provide protection to newborns beyond its intended purpose of fighting off TB has been known since at least the 1940s, but until now no one has been able to explain why or show how it works.

In a new study, published today in Science Translational Medicine, researchers reveal how they identified a dramatic and rapid increase in neutrophils — white blood cells that patrol the body and destroy invading bacterial pathogens – in mice and babies within three days of BCG vaccination.

The five-year study is the first to demonstrate the beneficial mechanism triggered by administration of BCG in newborns. It involved researchers from around the world, including senior co-authors Dr. Tobias Kollmann, an affiliate professor in the UBC department of paediatrics, and Dr. Nelly Amenyogbe, a graduate of UBC’s experimental medicine program. The study’s lead author Byron Brook, a UBC PhD candidate in experimental medicine, is based at the Kollmann Lab at BC Children’s Hospital Research Institute in Vancouver.

“It’s been known for a very long time that neutrophils play a very important role in managing sepsis, but until now nobody understood the role of BCG in initiating this critical process,” said Amenyogbe. “It was actually thought to be biologically implausible, however we’ve not only shown how BCG is involved, but that it kicks off this process almost instantly following vaccination — far more quickly than anticipated.”

The researchers first witnessed the phenomenon–known as emergency granulopoiesis (EG)–in mice, with the team later validating it in blood samples from newborn babies in West Africa and Papua New Guinea.

Kollmann, who also heads up the Systems Vaccinology team at Telethon Kids Institute (TKI) in Australia in partnership with the Perth Children’s Hospital Foundation, said the findings reinforce how critical it is for newborns in low-resource settings to receive BCG immediately after birth. Kollmann was previously the head of the paediatric division of infectious diseases at UBC before relocating to Australia.

“Less than half the babies who should get this vaccine right after birth actually get it then, partly because of logistics and partly because TB is not seen as a huge risk in those first few weeks. Administration is often delayed to four to six weeks, but by then it’s too late for many newborns,” said Kollmann, also an affiliate investigator at BC Children’s Hospital in Vancouver. “Around half of all newborn deaths from infection happen in the first week of life, with about 75 per cent of those deaths caused by sepsis. Given BCG’s clear role in helping newborns to fight off sepsis, we could save the lives of close to a million newborns every year if they were given this vaccine within days of birth instead of weeks later.”

Brook, the study’s lead author, added: “If every newborn was vaccinated with BCG, the greatest impact would be in regions of highest newborn mortality, specifically low- and middle-income countries. It could also help save newborns here in Canada, and represents a new strategy of how to get more benefit from existing vaccines.”

The researchers cautioned that while the effect was rapid and offered robust protection against newborn sepsis, it was relatively short-lived and did not occur in adult mice.

Kollmann and Amenyogbe are also involved in Australia’s BRACE trial, which is testing BCG’s potential to fight off COVID-19. Kollmann said whether BCG may or may not be protective against COVID-19 remains to be seen, but in the meantime, its real and proven potential to save the lives of vulnerable newborns had to be maximized.

“BCG is very, very safe, costs only a few cents per dose, and reduces infectious causes of mortality – not just tuberculosis – in newborns by almost 50 per cent,” Kollmann said. “There’s nothing that we have in our entire current medical arsenal that is as effective, cheap, safe, feasible and affordable as this vaccine. All we have to do is ensure all newborns at risk get it right away at birth.”

###

Media Contact
Kerry Blackadar
[email protected]
http://dx.doi.org/10.1126/scitranslmed.aax4517

Tags: Death/DyingDisease in the Developing WorldInfectious/Emerging DiseasesMedicine/HealthMortality/LongevityPediatricsPublic HealthVaccines
Share25Tweet16Share4ShareSendShare
  • How to MRI your dragon

    How to MRI your dragon: Illinois researchers develop first bearded dragon brain atlas

    74 shares
    Share 30 Tweet 19
  • Immune molecules from a llama could provide protection against a vast array of SARS-like viruses including COVID-19, researchers say

    74 shares
    Share 30 Tweet 19
  • Researchers perform non-line-of-sight ghost imaging with human vision

    73 shares
    Share 29 Tweet 18
  • Unique blend of comics and humor is key to success of public awareness posters in Singapore, finds Singapore-US researchers

    72 shares
    Share 29 Tweet 18
  • Human urine-derived stem cells have robust regenerative potential

    72 shares
    Share 29 Tweet 18
  • Researchers develop word-score model capable of estimating hidden hearing loss

    71 shares
    Share 28 Tweet 18
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

nTIDE May 2022 COVID Update: Uncertainty about inflation tempers good news for people with disabilities

COVID-19 fattens up our body’s cells to fuel its viral takeover

Famous Sterkfontein Caves deposit 1 million years older than previously thought

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 190 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....